What approach may enable a patient with Stage IIIA cancer to have breast-conserving surgery?

• A. Immediate surgery
• B. Postoperative chemotherapy
• C. Neoadjuvant chemotherapy
• D. Radiation therapy

Answer: (C)

Neoadjuvant chemotherapy is a treatment strategy where chemotherapy is administered before the main treatment, which in this case, is breast-conserving surgery. The primary goal of this approach is to shrink the tumor size and reduce the extent of the cancer. For patients with Stage IIIA cancer, which can have larger tumors or involve lymph nodes, neoadjuvant chemotherapy may make it feasible to perform a breast-conserving surgery instead of a mastectomy.

By effectively reducing the tumor through chemotherapy, surgeons can achieve clear margins and remove less breast tissue while still ensuring the cancer is adequately treated. This can significantly improve the patient's quality of life and cosmetic outcomes. Neoadjuvant chemotherapy is particularly advantageous because it allows for an assessment of how well the cancer responds to the treatment, which can be an important prognostic factor for subsequent therapies.

Other options, while relevant in different contexts, do not directly address the primary goal of enabling breast-conserving surgery in this scenario.